177 related articles for article (PubMed ID: 29019066)
1. Release Mechanism Between Ion Osmotic Pressure and Drug Release in Ionic-Driven Osmotic Pump Tablets (I).
Cheng L; Gao S; Ouyang D; Wang H; Wang Y; Pan W; Yang X
AAPS PharmSciTech; 2018 Feb; 19(2):803-811. PubMed ID: 29019066
[TBL] [Abstract][Full Text] [Related]
2. A controlled porosity osmotic pump system with biphasic release of theophylline.
Bi Y; Mao S; Gan L; Li Y; Wang C; Xu N; Zheng Y; Cheng Q; Hou S
Chem Pharm Bull (Tokyo); 2007 Nov; 55(11):1574-80. PubMed ID: 17978514
[TBL] [Abstract][Full Text] [Related]
3. Controlled release of ziprasidone solid dispersion systems from osmotic pump tablets with enhanced bioavailability in the fasted state.
Yanfei M; Guoguang C; Lili R; Pingkai O
Drug Dev Ind Pharm; 2015; 41(8):1353-62. PubMed ID: 25138348
[TBL] [Abstract][Full Text] [Related]
4. A novel time-controlled release system based on drug-resin complexes and elementary osmotic pump.
Wang C; Chen F; Heng PW; Li JZ; Li X; Ye GH; Nie SF; Pan WS
Chem Pharm Bull (Tokyo); 2008 Apr; 56(4):457-63. PubMed ID: 18379090
[TBL] [Abstract][Full Text] [Related]
5. Controlled release of glaucocalyxin - a self-nanoemulsifying system from osmotic pump tablets with enhanced bioavailability.
Yanfei M; Guoguang C; Lili R; Pingkai O
Pharm Dev Technol; 2017 Mar; 22(2):148-155. PubMed ID: 26400477
[TBL] [Abstract][Full Text] [Related]
6. Aqueous Polymer Dispersion Coating Used for Osmotic Pump Tablets: Membrane Property Investigation and IVIVC Evaluation.
Cheng L; Gai X; Wen H; Liu D; Tang X; Wang Y; Wang T; Pan W; Yang X
AAPS PharmSciTech; 2018 Jan; 19(1):242-250. PubMed ID: 28695327
[TBL] [Abstract][Full Text] [Related]
7. [The delivery mechanism of micro-porous osmotic pump tablets].
Zhao XL; Li Q; Gong XF; Li SM
Yao Xue Xue Bao; 2007 Feb; 42(2):226-30. PubMed ID: 17518057
[TBL] [Abstract][Full Text] [Related]
8. A controlled porosity osmotic pump system with biphasic release of theophylline: influence of weight gain on its in vivo pharmacokinetics.
Bi Y; Zhang Y; Zhao J; Mao S; Hou S
Chem Pharm Bull (Tokyo); 2008 Jun; 56(6):792-5. PubMed ID: 18520082
[TBL] [Abstract][Full Text] [Related]
9. A novel asymmetric membrane osmotic pump capsule with in situ formed delivery orifices for controlled release of gliclazide solid dispersion system.
Yang Y; Zhao Z; Wang Y; Yang L; Liu D; Yang X; Pan W
Int J Pharm; 2016 Jun; 506(1-2):340-50. PubMed ID: 27132166
[TBL] [Abstract][Full Text] [Related]
10. Novel osmotic pump tablet using core of drug-resin complexes for time-controlled delivery system.
Wang C; Chen F; Li JZ; Tang H; Li X; Yan KS; Ye GH; Pan WS
Yakugaku Zasshi; 2008 May; 128(5):773-82. PubMed ID: 18451626
[TBL] [Abstract][Full Text] [Related]
11. Development and Evaluation of a Once-Daily Controlled Porosity Osmotic Pump of Tapentadol Hydrochloride.
Thakkar HP; Pancholi N; Patel CV
AAPS PharmSciTech; 2016 Oct; 17(5):1248-60. PubMed ID: 26677859
[TBL] [Abstract][Full Text] [Related]
12. Application of hot-melt extrusion technology for designing an elementary osmotic pump system combined with solid dispersion for a novel poorly water-soluble antidepressant.
Zhang X; Wang M; Li P; Wang A; Liang R; Gai Y; Liu W; Li Y; Sun K
Pharm Dev Technol; 2016 Dec; 21(8):1006-1014. PubMed ID: 26446857
[TBL] [Abstract][Full Text] [Related]
13. Release characteristics and in vitro-in vivo correlation of pulsatile pattern for a pulsatile drug delivery system activated by membrane rupture via osmotic pressure and swelling.
Lin HL; Lin SY; Lin YK; Ho HO; Lo YW; Sheu MT
Eur J Pharm Biopharm; 2008 Sep; 70(1):289-301. PubMed ID: 18539015
[TBL] [Abstract][Full Text] [Related]
14. A novel bi-layer ascending release osmotic pump tablet: in vitro investigation and in vivo investigation in pharmacokinetic study and IVIVC evaluation.
Xu H; Li Z; Pan H; Zhang Z; Liu D; Tian B; Ma S; Song S; Pan W
Int J Pharm; 2013 Dec; 458(1):181-7. PubMed ID: 24095815
[TBL] [Abstract][Full Text] [Related]
15. Formulation design and characterization of an elementary osmotic pump tablet of flurbiprofen.
Patel KN; Mehta TA
PDA J Pharm Sci Technol; 2014; 68(4):333-46. PubMed ID: 25035256
[TBL] [Abstract][Full Text] [Related]
16. Influence of excipients, drugs, and osmotic agent in the inner core on the time-controlled disintegration of compression-coated ethylcellulose tablets.
Lin SY; Lin KH; Li MJ
J Pharm Sci; 2002 Sep; 91(9):2040-6. PubMed ID: 12210050
[TBL] [Abstract][Full Text] [Related]
17. Investigations of a novel self-emulsifying osmotic pump tablet containing carvedilol.
Wei L; Li J; Guo L; Nie S; Pan W; Sun P; Liu H
Drug Dev Ind Pharm; 2007 Sep; 33(9):990-8. PubMed ID: 17891586
[TBL] [Abstract][Full Text] [Related]
18. Preparation and
Li N; Fan L; Wu B; Dai G; Jiang C; Guo Y; Wang D
Drug Dev Ind Pharm; 2019 Jul; 45(7):1079-1088. PubMed ID: 30909753
[TBL] [Abstract][Full Text] [Related]
19. Zero-order release and bioavailability enhancement of poorly water soluble Vinpocetine from self-nanoemulsifying osmotic pump tablet.
El-Zahaby SA; AbouGhaly MHH; Abdelbary GA; El-Gazayerly ON
Pharm Dev Technol; 2018 Nov; 23(9):900-910. PubMed ID: 28540754
[TBL] [Abstract][Full Text] [Related]
20. Controlled release of metformin hydrochloride and repaglinide from sandwiched osmotic pump tablet.
Qin C; He W; Zhu C; Wu M; Jin Z; Zhang Q; Wang G; Yin L
Int J Pharm; 2014 May; 466(1-2):276-85. PubMed ID: 24607209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
